T. Aktas Et Al. , "Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies," FRONTIERS IN BIOSCIENCE-LANDMARK , vol.28, no.8, pp.171-180, 2023
Aktas, T. Et Al. 2023. Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies. FRONTIERS IN BIOSCIENCE-LANDMARK , vol.28, no.8 , 171-180.
Aktas, T., Kizmazoglu, D., Aktas, S., Erol, A., Serinan, E., Gokbayrak, O., ... Ozdemir, S. M.(2023). Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies. FRONTIERS IN BIOSCIENCE-LANDMARK , vol.28, no.8, 171-180.
Aktas, Tekincan Et Al. "Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies," FRONTIERS IN BIOSCIENCE-LANDMARK , vol.28, no.8, 171-180, 2023
Aktas, Tekincan Et Al. "Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies." FRONTIERS IN BIOSCIENCE-LANDMARK , vol.28, no.8, pp.171-180, 2023
Aktas, T. Et Al. (2023) . "Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies." FRONTIERS IN BIOSCIENCE-LANDMARK , vol.28, no.8, pp.171-180.
@article{article, author={Tekincan Aktas Et Al. }, title={Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies}, journal={FRONTIERS IN BIOSCIENCE-LANDMARK}, year=2023, pages={171-180} }